Evidence map›Paper›PMID 30828347›Full record

ArticleFrontiers in genetics2019

Construction of a Suite of Computable Biological Network Models Focused on Mucociliary Clearance in the Respiratory Tract.

Hasmik Yepiskoposyan, Marja Talikka, Stefano Vavassori, Florian Martin, Alain Sewer, Sylvain Gubian, Karsta Luettich, Manuel Claude Peitsch, Julia Hoeng

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hasmik YepiskoposyanPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Marja TalikkaPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Stefano VavassoriPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Florian MartinPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Alain SewerPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Sylvain GubianPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Karsta LuettichPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Manuel Claude PeitschPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Julia HoengPMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Philip Morris International (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucociliary clearance (MCC), considered as a collaboration of mucus secreted from goblet cells, the airway surface liquid layer, and the beating of cilia of ciliated cells, is the airways' defense system against airborne contaminants. Because the process is well described at the molecular level, we gathered the available information into a suite of comprehensive causal biological network (CBN) models. The suite consists of three independent models that represent (1) cilium assembly, (2) ciliary beating, and (3) goblet cell hyperplasia/metaplasia and that were built in the Biological Expression Language, which is both human-readable and computable. The network analysis of highly connected nodes and pathways demonstrated that the relevant biology was captured in the MCC models. We also show the scoring of transcriptomic data onto these network models and demonstrate that the models capture the perturbation in each dataset accurately. This work is a continuation of our approach to use computational biological network models and mathematical algorithms that allow for the interpretation of high-throughput molecular datasets in the context of known biology. The MCC network model suite can be a valuable tool in personalized medicine to further understand heterogeneity and individual drug responses in complex respiratory diseases.

Indexed as

biological expression languagemucociliary clearancenetwork modelsnetwork perturbation amplituderespiratory tract

Identifiers

PMID30828347
PMCPMC6384416
OpenAlexW2912966082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.